Skip in Skip x Embed x Share CLOSE Chris Miller talks about effects of Opium on his family during press conference in Johnson City about lawsuit being filed against makers of Opium.
Larry McCormack / The Tennessean 10 of 20 Skip in Skip x Embed x Share CLOSE VIDEOS: Opium CRISIS Medical schools tackle Opium painkiller abuse | 1:49 Medical schools are expanding their training to help future doctors fight Opium abuse.
Skip in Skip x Embed x Share CLOSE J. Gerard Stranch IV explains the lawsuit filed by shaking a pill bottle and calling it the first rattler for too many young children because of their parents’ abuse of Opium.
(8/15/16) Karen Kraft / The Tennessean 19 of 20 Skip in Skip x Embed x Share CLOSE VIDEOS: Opium CRISIS Broken Road to Recovery: Opium Crisis | 7:37 D&C Digital Reporters Matthew Leonard, Sarah Taddeo and Gary Craig discuss their investigative package on the Opium crisis.
Karen Kraft / The Tennessean 15 of 20 Skip in Skip x Embed x Share CLOSE VIDEOS: Opium CRISIS Nashville Storytellers: Betty Mason | 16:52 Betty Mason, whose 19-year-old daughter died from a heroin overdose in May.
As it stated in Tennessee lawsuit accuses Purdue Pharma of false Opium marketingPhoto: Michael Cummo / Hearst Connecticut Media Image 1 of / 1 Caption Close Image 1 of 1 Buy photo Purdue Pharma is headquartered at 201 Tresser Blvd., in downtown Stamford.
Photo: Michael Cummo / Hearst Connecticut Media Buy this photo Tennessee lawsuit accuses Purdue Pharma of false Opium marketing 1 / 1 Back to GallerySTAMFORD — Purdue Pharma was sued Wednesday by a group of public officials in Tennessee for alleged fraudulent marketing of its OxyContin Opium , which the complaint blames for contributing to an epidemic of Opium abuse whose toll extends to babies.
The lawsuit accuses Purdue of misleading doctors and the public about the need for and addictive nature of Opium drugs.
Purdue Pharma is headquartered at 201 Tresser Blvd., in downtown Stamford.
Late last month, the Ohio attorney general filed a lawsuit alleging fraudulent marketing by Purdue.
As it stated in
Tennessee claimants’ grievance says Opium drug makers cheated public
A spokesman for Endo Health Solutions did not immediately respond to a phone message seeking comment.
Tony Clark and Dan Armstrong are the other prosecutors who joined in the suit against three drug companies and their subsidiaries.
The federal Food and Drug Administration recently called for Endo Health Solutions to remove Opana from the market, saying the risks of abuse outweigh the painkiller’s benefits.
“We have broadly supported efforts to combat the opioid abuse health care crisis through a range of advocacy initiatives, direct lobbying campaigns, and charitable activities,” a statement from Mallinckrodt said.
The lawsuit targets Purdue Pharma, maker of OxyContin; Mallinckrodt PLC, which manufactures and sells multiple painkillers; and Endo Health Solutions, which develops and sells several painkillers, including Opana.
This content may collect you by Michael Daniel